Kovack Advisors, Inc. Vertex Pharmaceuticals Inc Transaction History

Kovack Advisors, Inc.

$887 Million
Q2 2024

A detailed history of Kovack Advisors, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kovack Advisors, Inc. holds 1,212 shares of VRTX stock, worth $574,681. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,212

Previous 1,085 11.71%

Holding current value

$574,681

Previous $453,000 25.39%

% of portfolio

0.06%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$392.81 - $485.53 $49,886 - $61,662	127 Added 11.71%	1,212 $568,000
Q1 2024 Apr 19, 2024	BUY	$407.69 - $446.08 $2,038 - $2,230	5 Added 0.46%	1,085 $453,000
Q4 2023 Feb 02, 2024	BUY	$343.0 - $410.68 $14,063 - $16,837	41 Added 3.95%	1,080 $439,000
Q3 2023 Oct 19, 2023	BUY	$338.18 - $362.46 $25,701 - $27,546	76 Added 7.89%	1,039 $361,000
Q2 2023 Jul 21, 2023	SELL	$314.42 - $351.91 $16,664 - $18,651	-53 Reduced 5.22%	963 $338,000
Q1 2023 Apr 20, 2023	BUY	$283.23 - $323.1 $20,109 - $22,940	71 Added 7.51%	1,016 $320,000
Q4 2022 Feb 22, 2023	BUY	$285.76 - $321.48 $23,432 - $26,361	82 Added 9.5%	945 $272,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $219,611 - $245,035	-802 Reduced 48.17%	863 $250,000
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $272,788 - $339,650	-1,161 Reduced 41.08%	1,665 $469,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $159,643 - $188,159	721 Added 34.25%	2,826 $737,000
Q4 2021 Jan 18, 2022	BUY	$177.01 - $223.45 $372,606 - $470,362	2,105 New	2,105 $462,000
Q1 2021 May 04, 2021	SELL	$207.02 - $241.31 $226,479 - $263,993	-1,094 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$207.01 - $276.09 $107,645 - $143,566	-520 Reduced 32.22%	1,094 $259,000
Q3 2020 Nov 02, 2020	BUY	$255.65 - $303.1 $34,768 - $41,221	136 Added 9.2%	1,614 $439,000
Q2 2020 Jul 31, 2020	BUY	$225.48 - $295.8 $15,558 - $20,410	69 Added 4.9%	1,478 $429,000
Q1 2020 Apr 30, 2020	BUY	$199.77 - $247.81 $281,475 - $349,164	1,409 New	1,409 $335,000
Q3 2019 Oct 31, 2019	SELL	$166.23 - $187.09 $192,328 - $216,463	-1,157 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $42,140 - $48,734	-256 Reduced 18.12%	1,157 $212,000
Q1 2019 May 03, 2019	SELL	$163.73 - $194.7 $11,624 - $13,823	-71 Reduced 4.78%	1,413 $260,000
Q4 2018 Feb 06, 2019	BUY	$151.91 - $192.21 $9,114 - $11,532	60 Added 4.21%	1,484 $246,000
Q3 2018 Oct 09, 2018	BUY	$167.73 - $192.74 $238,847 - $274,461	1,424 New	1,424 $274,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Account

Kovack Advisors, Inc. Vertex Pharmaceuticals Inc Transaction History